Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Design Thinking & The Rheumatologist

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  Issue: October 2023  |  October 11, 2023

In our clinical settings, testing can best be thought of as follow-up to initiating a treatment. The real test is in knowing whether a medication or other therapy is having its intended main effect while reducing its side effects. Key to our understanding of any therapy is that there is no guarantee of its success—only a likelihood of success or not. To expand upon that a little, testing means critically listening to patients to identify what elements of the prototype have to be modified for it to work—or if we have to consider another form of prototype altogether.

This brings us back to the beginning—because design-thinking never really ends. In fact, even as soon as this redesign of The Rheumatologist is tested and implemented, we’ll continue to listen to you, our readers, and restart this cycle with deep empathy. Perhaps in the next incarnation of the redesign process, elements will change further, or remain the same, or perhaps even revert to how it was before. That’s the great thing about design—without the infusion of empathy at all stages of the process, it doesn’t quite work.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Love of The Rheumatologist

There we have it—the five stages of design thinking: empathize, define, ideate, prototype and test. We see and encounter these stages all around us, but they are so subtle we often don’t even notice them. Throughout this process of redesigning The Rheumatologist, I’ve paid close attention to these stages and the cycles that we’ve gone through. It’s been an enlightening experience that comes out of a deeper feeling that is less described in the literature about design thinking: Love. The love of rheumatology, the love of our readers and the love of writing.

As you scan your eyes around, either on the page or online, I hope you enjoy the details as much as we enjoyed crafting them.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS, is the associate program director of the rheumatology fellowship training program at the University of Iowa, Iowa City, and the physician editor of The Rheumatologist. Follow him on X (formerly Twitter) @BharatKumarMD.

References

  1. Arnold JE, Clancey WJ. Creative Engineering: Promoting Innovation by Thinking Differently. John E. Arnold Jr. and William J. Clancey; 2016. https://tinyurl.com/4mv7kjzs.
  2. Design thinking: Solving the right problems. Thales Group. https://tinyurl.com/ytfeewrj.
  3. What are wicked problems? Interaction Design Foundation. https://tinyurl.com/yc83eyxv.
  4. Landry L. What is human-centered design? Harvard Business School. 2020 Dec 15. https://tinyurl.com/5y4h8pnd.
  5. Dam RF. The 5 stages in the design thinking process. Interaction Design Foundation. 2022. https://tinyurl.com/mvfktmuj.
  6. Pitkin RM. Listen to the patient. BMJ. 1998 Apr 18;316(7139):1252.
  7. Goodfellow LT. An overview of survey research. Respir Care. 2023 Sep;68(9):1309–1313.
  8. Tausch AP, Menold N. Methodological aspects of focus groups in health research: Results of qualitative interviews with focus group moderators. Glob Qual Nurs Res. 2016 Mar 14;3:2333393616630466.
  9. Aflatoony L, Hepburn K, Perkins MM, et al. Training clinical researchers with design thinking to develop dementia caregiving research initiatives. Design Health (Abingdon). 2022;6(1):69–90.
  10. Abookire S, Plover C, Frasso R, Ku B. Health design thinking: An innovative approach in public health to defining problems and finding solutions. Front Public Health. 2020 Aug 28;8:459.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionRheuminations Tagged with:DiagnosisEmpathy

Related Articles

    The Science of Empathy in Rheumatology

    January 19, 2021

    Rheumatology has arguably benefited like no other field from the proliferation of an increasingly effective pipeline of therapeutics. These medications have dramatically raised the bar for clinical outcomes for our patients in a way that we could not have envisioned a short generation ago. With such therapeutic progress now reaching a widening circle of rheumatic…

    Janusian Thinking in Rheumatology

    January 17, 2023

    Happy New Year, readers of The Rheumatologist! As the incoming editor, I want to welcome you back in this new year and hope that you’ll stick around, month after month, as we journey together through 2023. As the year progresses, you may notice some departures from what we have previously done, but I also wish…

    Mitigate Risk and Increase Success of Lupus Clinical Trials

    August 1, 2010

    Design strategies from a Lupus Research Institute conference

    Letter: Empathy in Medicine

    April 17, 2021

    For years now, I have read The Rheumatologist cover to cover (but only glance at the ads, but don’t tell the advertisers that). Len Calabrese’s piece, “The Science of Empathy in Rheumatology” in the January 2021 issue, hits the central point in medical care. I would like to believe that it has been empathy that…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences